Business
Lattice Biologics Ltd. Receives Multi-Year American Association of Tissue Banks Re-Accreditation
Lattice Biologics Ltd. Receives Multi-Year American Association of Tissue Banks Re-Accreditation.
About this update from Lattice Biologics Ltd
[{"type":"text","content":"\nLattice Biologics Ltd. Receives Multi-Year American Association of Tissue Banks Re-Accreditation\n\nLattice Biologics Ltd. Receives Multi-Year American Association of Tissue Banks Re-Accreditation\n\n\nAccreditation Demonstrates Commitment to Highest Standards for Patients and the Medical Community\n\n SCOTTSDALE, AZ--(Marketwired - June 01, 2017) - Lattice Biologics Ltd. (TSX VENTURE: LBL) (OTCQB: LBLTF) (\"Lattice Biologics\" or the \"Company\") is pleased to announce that it has been approved for re-accreditation by the American Association of Tissue Banks (\"AATB\") for processing, storage, and distribution of musculoskeletal tissue and skin through September 2019.The multi-year accreditation was received following a process including on-site inspections and audits of the Company's tissue processing facility in Scottsdale, Arizona. The approval establishes that Lattice Biologics meets or exceeds the AATB's Standards for Tissue Banking, which are recognized in the United States and around the world as the definitive guide for tissue banking.\"This voluntary accreditation demonstrates Lattice Biologics' longstanding commitment to a strong quality control environment and respect for the highest standards for patients and the medical community,\" said Guy Cook, CEO of Lattice Biologics. \"We are excited to secure this key approval which will advance the Company and its sales objectives.\"Lattice continues to develop products in the following five areas: 1) musculoskeletal products used primarily in spine indications; 2) Accelular Dermal Matrix used in breast reconstruction and sports medicine; 3) demineralized bone matrix putty; 4) precision diagnostics tools for cancer screening; and 5) amnion based products. The Company has successfully increased production levels to meet surgeon demand and is having great success with the launch of its two newest products, the Accellular Dermal Matrix scaffold (AdMatrix) and the amnion based products, AmnioBoost and AmnioBlast. About the American Association of Tissue Banks:The AATB is a professional, non-profit, scientific and educational organization that has been accrediting tissue banks since 1986. It is the only national tissue banking organization in the United States, and its membership totals more than 130 accredited tissue banks and 2,000 individual members. These institutions dist...